Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- pharma
Edetate calcium disodium
CAS 23411-34-9
Concern score
Not assessed — no hazard data yet.
Why it's flagged
Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Potency: 0.01 %w/v
Regulation
No restrictions found. Edetate calcium disodium appears in these published regulatory listings.
- currently_marketed_ndc
- definition_level:complete
- definition_type:primary
- inactive_ingredient_database
- ingredient_type:ingredient substance
- marketed_drug_ingredient
- nsde_reference_present
- substance_class:chemical
USFDAinactive ingredient database26 entries — 11 administration routes
- Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Potency: 0.01 %w/vSource →
- Route: INTRA-ARTERIAL; Dosage form: INJECTION; Maximum daily exposure: 25 mgSource →
- Route: INTRA-ARTERIAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 25 mgSource →
- Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 0.05 %w/vSource →
- Route: INTRATHECAL; Dosage form: INJECTION; Potency: 2.16 mgSource →
- Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: 100 mgSource →
- Route: INTRAVASCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 108 mgSource →
- Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 25 mgSource →
- Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 108 mgSource →
- Route: INTRAVESICAL; Dosage form: SOLUTION; Potency: 0.11 mgSource →
- Route: ORAL; Dosage form: CAPSULE; Potency: NASource →
- Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: NASource →
- Route: ORAL; Dosage form: CONCENTRATE; Potency: 0.25 mg/1mlSource →
- Route: ORAL; Dosage form: DROPS; Potency: NASource →
- Route: ORAL; Dosage form: ELIXIR; Potency: 5 mg/5mlSource →
- Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: 0.22 mgSource →
- Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: NASource →
- Route: ORAL; Dosage form: SUSPENSION; Potency: NASource →
- Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 4 mgSource →
- Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 0.4 mgSource →
- Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Potency: 0.78 mgSource →
- Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 5 mgSource →
- Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.06 %w/vSource →
- Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 2 mgSource →
- Route: TOPICAL; Dosage form: SOLUTION; Potency: 0.01 %w/vSource →
- Route: URETHRAL; Dosage form: SOLUTION; Potency: 0.01 %w/vSource →
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 1 active drug products and 1 total products.
- FDA NDC lists this ingredient in 1 active drug products and 1 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
- openFDA substance registry classifies this ingredient as chemical.Source →
Evidence
No graded sources yet for Edetate calcium disodium. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Where it appears
Prevalence of Edetate calcium disodium in our catalog (fda_ndc).
Products
1
